159 related articles for article (PubMed ID: 25082635)
1. [Viscum album L. (Iscador) in the cat: tolerance, adverse reactions and indications].
Glardon ; Pache ; Magnenat ; Pin ; Parvis
Schweiz Arch Tierheilkd; 2014 Aug; 156(8):381-8. PubMed ID: 25082635
[TBL] [Abstract][Full Text] [Related]
2. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
3. Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.
Büssing A; Stumpf C; Tröger W; Schietzel M
Anticancer Res; 2007; 27(4C):2903-10. PubMed ID: 17695469
[TBL] [Abstract][Full Text] [Related]
4. Disappearance of an advanced adenomatous colon polyp after intratumoural injection with Viscum album (European mistletoe) extract: a case report.
von Schoen-Angerer T; Goyert A; Vagedes J; Kiene H; Merckens H; Kienle GS
J Gastrointestin Liver Dis; 2014 Dec; 23(4):449-52. PubMed ID: 25532007
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M).
Kirsch A
J Altern Complement Med; 2007 May; 13(4):443-5. PubMed ID: 17532738
[TBL] [Abstract][Full Text] [Related]
6. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
[TBL] [Abstract][Full Text] [Related]
7. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
8. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
Kienle GS; Grugel R; Kiene H
BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
[TBL] [Abstract][Full Text] [Related]
9. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory and clinical effects of Viscum album (Iscador M and Iscador P) in children with recurrent respiratory infections as a result of the Chernobyl nuclear accident.
Chernyshov VP; Heusser P; Omelchenko LI; Chernyshova LI; Vodyanik MA; Vykhovanets EV; Galazyuk LV; Pochinok TV; Gaiday NV; Gumenyuk ME; Zelinsky GM; Schaefermeyer H; Schaefermeyer G
Am J Ther; 2000 May; 7(3):195-203. PubMed ID: 11317168
[TBL] [Abstract][Full Text] [Related]
11. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
Grossarth-Maticek R; Ziegler R
Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
[TBL] [Abstract][Full Text] [Related]
12. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
13. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
Braedel-Ruoff S
Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
[TBL] [Abstract][Full Text] [Related]
15. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
Schad F; Axtner J; Kröz M; Matthes H; Steele ML
Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
[TBL] [Abstract][Full Text] [Related]
16. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
Wrotek S; Skawiński R; Kozak W
Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
[TBL] [Abstract][Full Text] [Related]
17. Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.
Büssing A; Tröger W; Stumpf C; Schietzel M
Anticancer Res; 2008; 28(3B):1893-7. PubMed ID: 18630477
[TBL] [Abstract][Full Text] [Related]
18. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
